MNPR earnings: a negative outcome, -6.6%

On May 11, 2023, Monopar Therapeutics reached its earnings. The result was a negative outcome, and the stock moved -6.6% in the window around the event. It had already run -21.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.